openPR Logo
Press release

Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017

10-25-2017 01:05 PM CET | Health & Medicine

Press release from: Arizton Advisory & Intelligence

Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017

Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017

The “Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017″ report provides a comprehensive analysis of HDAC drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential HDAC inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding, patent, and USFDA and EMA designations. It also assesses the pipeline HDAC inhibitors by monotherapy, combination products, molecule type and route of administration. In addition to analysis on active pipeline molecules, the report also provides detailed information about discontinued and dormant drugs.

View report: https://www.arizton.com/reports/pharma-pipeline-analysis/histone-deacetylase-hdac-inhibitors-pipeline-insights

The report profiles key players in developing potential HDAC drug candidates. The company profile section provides details such as company overview, business overview, financial overview, product portfolio, business strategies, and recent developments.

Related Reports
1) Tumor Necrosis Factor Alpha (TNF-a) Inhibitors - Pipeline Insights 2017

https://www.arizton.com/reports/pharma-pipeline-analysis/tumor-necrosis-factor-alpha-tnf-a-inhibitors-pipeline-insights

2) Chimeric Antigen Receptor (CAR) T Cell Immunotherapy - Pipeline Insights 2017

https://www.arizton.com/reports/pharma-pipeline-analysis/chimeric-antigen-receptor-car-t-cell-immunotherapy-pipeline-insights-2017

About Arizton
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize foolproof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-465-7864

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017 here

News-ID: 785399 • Views:

More Releases from Arizton Advisory & Intelligence

The US Data Center Construction Market Investment to Reach $47.72 Billion by 202 …
According to Arizton's latest research report, the U.S. data center construction market is growing at a CAGR of 11.69% during 2023-2029.  To Know More, Click: https://www.arizton.com/market-reports/united-states-data-center-construction-market-2024 The US data center construction market is witnessing robust growth, fueled by surging demand for data storage and processing capabilities. Major players across tech, real estate, and infrastructure sectors are investing significantly in building and upgrading data centers. This demand surge is propelled by
Exclusive Focus Insight Report by Arizton Predicts, the US Pool Maintenance and Cleaning Services Market on Upward Trajectory, the Market to Reach $10.33 Billion by 2029
Exclusive Focus Insight Report by Arizton Predicts, the US Pool Maintenance and …
According to Arizton's latest focus research report, the US pool maintenance and cleaning service market is growing at a CAGR of 4.17% during 2023-2029. To Know More, Click: https://www.focusreports.store/report/us-pool-maintenance-and-cleaning-services-market The market is growing significantly due to advances in the pool technology, shift toward sustainability practices, rising popularity of subscription-based pool services, growing awareness of chemical balancing for above-ground pools, the growing demand for pool opening and closing services, the increasing demand
The US Neonatal Incubators Market to Reach $121.11 Million by 2029 - Exclusive Focus Insight Report by Arizton
The US Neonatal Incubators Market to Reach $121.11 Million by 2029 - Exclusive F …
According to Arizton's latest focus insight report, the US Neonatal incubators market is growing at a CAGR of 3.57% during 2023-2029.   To Know More, Click: https://www.focusreports.store/report/us-neonatal-incubators-market The infant incubator market is highly fragmented, with many producers in the US. To meet the surging consumer demand and expand their customer base, these companies are implementing various tactics such as mergers & acquisitions, partnerships & collaborations, and new product launches. Owing to the
The US Sleep Supplements Market to Reach $1.45 Billion by 2029 - Exclusive Focus Insight Report by Arizton
The US Sleep Supplements Market to Reach $1.45 Billion by 2029 - Exclusive Focus …
According to Arizton's latest research report, the US sleep supplements market is growing at a CAGR of 5.97% during 2023-2029.   To Know More, Download the Free Sample Report: https://www.focusreports.store/report/us-sleep-supplements-market The US sleep supplements market is growing significantly due to a surge in online sales and increasing demand for plant-based options. Lifestyle factors such as stress, irregular sleep patterns, and changing demographics, notably an aging population and health-conscious millennials, are driving this

All 5 Releases


More Releases for HDAC

Histone Deacetylase (HDAC) Inhibitors Market 2022 | Detailed Report
The Histone Deacetylase (HDAC) Inhibitors research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about the
HDAC Inhibitors Market - Increasing R&D activities for cancer is expected to boo …
Overview HDAC inhibitors are a kind of anti-cancer drug that works by causing cell cycle arrest, apoptosis, and death in cancer cells through non-epigenetic or epigenetic control. HDAC inhibitors (HDACi) are potential medicines that have already demonstrated promise in oncological applications such as cancer detection, treatment, and prognostic. Vorinostat (Merck & Co. Inc.) is a new medication that is used to treat epidermal T cell lymphoma as it progresses, relapses, or
HDAC Inhibitors Market - Trends and Opportunities 2017 - 2025
Regional segmentation of HDAC inhibitors market by Coherent Market Insights, includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the market due to growing incidence of cancer and rising demand for cancer therapeutics in the region. According to American Cancer Society, in 2017, 1,688,780 new cancer cases and 600,920 deaths due to cancer are estimated to occur
Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
The “Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017″ report provides a comprehensive analysis of HDAC drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential HDAC inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding,
Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017
The “Histone Deacetylase (HDAC) Inhibitors - Pipeline Insights 2017″ report provides a comprehensive analysis of HDAC drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential HDAC inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding,
Histone Deacetylase (HDAC) Inhibitor Market Research Report 2017
Reports And Markets Publish a New Market Research Report On –"Histone Deacetylase (HDAC) Inhibitor Market Research Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-histone-deacetylase-hdac-inhibitor-market-research-report-2017-1541214 In this report, the global Histone Deacetylase (HDAC) Inhibitor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented